Kidney Disease in the Setting of Liver Failure: Core Curriculum 2013

Slides:



Advertisements
Similar presentations
Volume 350: April 15, 2004 Number 16 Management of Cirrhosis and Ascites Pere Ginès, M.D., Andrés Cárdenas, M.D., Vicente Arroyo, M.D., and Juan.
Advertisements

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Organ Trafficking: Global Solutions for a Global Problem
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Renal Function Testing
Ascites and Hepatorenal Syndrome: Pathophysiology and Management
Cláudia Fagundes, MD, Pere Ginès, MD, PhD 
Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016  Angela C. Webster, PhD, Evi V. Nagler, MD,
Acute Kidney Injury in Patients With Cirrhosis: Perils and Promise
Lilia Cervantes, Monica Grafals, Rudolph A. Rodriguez 
Diagnosis and Treatment of Hyponatremia
Fibroblast Growth Factor 23 and CKD Prognosis
Vasoconstrictor Therapy for the Hepatorenal Syndrome
New Developments in Hepatorenal Syndrome
Portal Hypertension and Its Complications
Peritoneal dialysis American Journal of Kidney Diseases
Changing Terminology in Renal Research: The Impact of Consensus
Susan P.Y. Wong, MD, Ann M. O'Hare, MD, MA 
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
Metabolic Complications in Elderly Adults With CKD
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Care of the Undocumented Immigrant in the United States With ESRD
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Update on Nephrolithiasis: Core Curriculum 2016
A Decade After the KDOQI CKD Guidelines
Caring for Undocumented Immigrants With Kidney Disease
The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective  Gregorio T. Obrador, MD, MPH, Ximena Rubilar,
Pathophysiology and Management of Preeclampsia-Associated Severe Hyponatremia  Gagangeet Sandhu, MD, Senthil Ramaiyah, MD, Germaine Chan, MD, Ira Meisels,
CKD and Poverty: A Growing Global Challenge
Quiz Page July 2009 American Journal of Kidney Diseases
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
Jayme E. Locke, MD, MPH  American Journal of Kidney Diseases 
Evaluation of the Potential Living Kidney Donor
Vicente Arroyo, Carlos Terra, Pere Ginès  Journal of Hepatology 
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Glycemic Management in ESRD and Earlier Stages of CKD
Salt and Hypertension American Journal of Kidney Diseases
Greg A. Knoll, MD, MSc  American Journal of Kidney Diseases 
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
A New Era of Renal Denervation Trials for Patients With Hypertension?
Hypertension After Kidney Transplant
Urinary Indices and Microscopy in Sepsis-Related Acute Renal Failure
IgA Nephropathy: Progress Before and Since Berger
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
A Timely Evaluation of the Psychometric Properties of the KDQOL-36
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Organ Trafficking: Global Solutions for a Global Problem
Study Designs in Patient-Oriented Research
Evidence and Outcomes in CKD
Erratum American Journal of Kidney Diseases
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Arnold S. Relman, MD, American Journal of Kidney Diseases
Trial Quality in Nephrology: How Are We Measuring Up?
Erratum American Journal of Kidney Diseases
In the Literature: Cognitive Impairment in Hemodialysis Patients
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Gregory Proctor, MD, Stuart Linas, MD 
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
Decongestive Treatment of Acute Decompensated Heart Failure: Cardiorenal Implications of Ultrafiltration and Diuretics  Benjamin J. Freda, DO, Mara Slawsky,
Dialysis Research and N-of-1 Trials: Made for Each Other?
Renal dysfunction in cirrhosis is not just a vasomotor nephropathy
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
Presentation transcript:

Kidney Disease in the Setting of Liver Failure: Core Curriculum 2013 Thomas A. Gonwa, MD, Hani M. Wadei, MD  American Journal of Kidney Diseases  Volume 62, Issue 6, Pages 1198-1212 (December 2013) DOI: 10.1053/j.ajkd.2013.07.017 Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Mechanisms leading to circulatory and decreased kidney function in cirrhosis. The main mechanism is progressive splanchnic arterial vasodilatation due to overproduction of vasodilator molecules. During the initial phases of decompensated cirrhosis, when activation of vasoconstrictor systems is moderate, patients develop sodium retention and ascites. In subsequent stages, activation of antidiuretic hormone (ADH) leads to dilutional hyponatremia. Finally, in the most advanced phase, when circulatory dysfunction is extreme, renal vasodilatory systems are overcome and patients develop severe renal vasoconstriction and type 2 hepatorenal syndrome (HRS). Abbreviations: RAAS, renin–angiotensin–aldosterone system; SNS, sympathetic nervous system. Reprinted from Arroyo et al (Nature Reviews Nephrology. 2011;7:517-526), with permission of Macmillan Publishers Ltd. American Journal of Kidney Diseases 2013 62, 1198-1212DOI: (10.1053/j.ajkd.2013.07.017) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Probability of survival of a recent cohort of 116 patients who developed either type 1 (solid line) or type 2 (dotted line) hepatorenal syndrome between April 2007 and February 2009. Adapted from Salerno et al (J Hepatol. 2011;55:1241-1248), with permission of Elsevier. American Journal of Kidney Diseases 2013 62, 1198-1212DOI: (10.1053/j.ajkd.2013.07.017) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Number of simultaneous liver-kidney transplantations in the United States by year and their percentage of total deceased donor liver transplantations. Health Resources and Services Administration/Organ Procurement and Transplantation Network data as of December 31, 2012. Source www.optn.transplant.hrsa.gov. American Journal of Kidney Diseases 2013 62, 1198-1212DOI: (10.1053/j.ajkd.2013.07.017) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions